These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 1971978

  • 1. [Specific and nonspecific effects of beta receptor blockers: stereoselectively different properties exemplified by (R)- and (S)-propranolol].
    Stoschitzky K, Lindner W.
    Wien Med Wochenschr; 1990 Apr 15; 140(6-7):156-62. PubMed ID: 1971978
    [Abstract] [Full Text] [Related]

  • 2. [Pharmacological basis for the therapy of cardiovascular disease with beta-adrenoceptor blocking drugs (author's transl)].
    Lemmer B.
    Herz; 1982 Jun 15; 7(3):168-78. PubMed ID: 6124492
    [Abstract] [Full Text] [Related]

  • 3. Stereoselective increase of plasma concentrations of the enantiomers of propranolol and atenolol during exercise.
    Stoschitzky K, Kahr S, Donnerer J, Schumacher M, Luha O, Maier R, Klein W, Lindner W.
    Clin Pharmacol Ther; 1995 May 15; 57(5):543-51. PubMed ID: 7768077
    [Abstract] [Full Text] [Related]

  • 4. Stereospecific pharmacokinetics and pharmacodynamics of beta-adrenergic blockers in humans.
    Mehvar R, Brocks DR.
    J Pharm Pharm Sci; 2001 May 15; 4(2):185-200. PubMed ID: 11466176
    [Abstract] [Full Text] [Related]

  • 5. The receptor binding profile of the new antihypertensive agent nebivolol and its stereoisomers compared with various beta-adrenergic blockers.
    Pauwels PJ, Gommeren W, Van Lommen G, Janssen PA, Leysen JE.
    Mol Pharmacol; 1988 Dec 15; 34(6):843-51. PubMed ID: 2462161
    [Abstract] [Full Text] [Related]

  • 6. Do we need a new classification of beta-blockers?
    Kendall MJ.
    J Hum Hypertens; 1990 Jun 15; 4 Suppl 2():27-9. PubMed ID: 1973460
    [Abstract] [Full Text] [Related]

  • 7. Central hemodynamics of beta-adrenoceptor blocking drugs: beta 1 selectivity versus intrinsic sympathomimetic activity.
    Svendsen TL.
    J Cardiovasc Pharmacol; 1983 Jun 15; 5 Suppl 1():S21-5. PubMed ID: 6188916
    [Abstract] [Full Text] [Related]

  • 8. Effects of (-)-RO363 at human atrial beta-adrenoceptor subtypes, the human cloned beta 3-adrenoceptor and rodent intestinal beta 3-adrenoceptors.
    Molenaar P, Sarsero D, Arch JR, Kelly J, Henson SM, Kaumann AJ.
    Br J Pharmacol; 1997 Jan 15; 120(2):165-76. PubMed ID: 9117106
    [Abstract] [Full Text] [Related]

  • 9. [beta-Adrenergic receptor blockers--a group of chiral drugs: different effects of each enantiomer].
    Cizmáriková R.
    Ceska Slov Farm; 2002 May 15; 51(3):121-8. PubMed ID: 12058352
    [Abstract] [Full Text] [Related]

  • 10. [Effects of various beta-receptor blockers on metabolic and circulatory parameters during physical exertion].
    Koebe P, Rost R, Reinke A, Nagel N, Merten U.
    Arzneimittelforschung; 1985 May 15; 35(2):522-9. PubMed ID: 2859861
    [Abstract] [Full Text] [Related]

  • 11. Antihypertensive effects of 12 beta adrenoceptor antagonists in conscious spontaneously hypertensive rats: relationship to changes in plasma renin activity, heart rate and sympathetic nerve function.
    Antonaccio MJ, High J, DeForrest JM, Sybertz E.
    J Pharmacol Exp Ther; 1986 Jul 15; 238(1):378-87. PubMed ID: 2873238
    [Abstract] [Full Text] [Related]

  • 12. Beta blockers: the extended family.
    Hager WD, Messineo FC, Katz AM.
    Adv Intern Med; 1984 Jul 15; 30():201-29. PubMed ID: 6152107
    [Abstract] [Full Text] [Related]

  • 13. Stereoselective features of (R)- and (S)-atenolol: clinical pharmacological, pharmacokinetic, and radioligand binding studies.
    Stoschitzky K, Egginger G, Zernig G, Klein W, Lindner W.
    Chirality; 1993 Jul 15; 5(1):15-9. PubMed ID: 8383518
    [Abstract] [Full Text] [Related]

  • 14. [Beta-adrenergic receptor blockers in clinical practice].
    Czuriga I, Edes I.
    Orv Hetil; 2004 Sep 19; 145(38):1951-60. PubMed ID: 15535106
    [Abstract] [Full Text] [Related]

  • 15. [Effect of a beta 2-blocker on the adrenergic receptors of lymphocytes in hypertension].
    Krasnikova TL, Radiukhin VA, Parfenova EV, Suvorov IuI, Ustinova SE.
    Biull Eksp Biol Med; 1986 Jul 19; 102(7):46-8. PubMed ID: 2873850
    [Abstract] [Full Text] [Related]

  • 16. Racemic (R,S)-propranolol versus half-dosed optically pure (S)-propranolol in humans at steady state: Hemodynamic effects, plasma concentrations, and influence on thyroid hormone levels.
    Stoschitzky K, Lindner W, Egginger G, Brunner F, Obermayer-Pietsch B, Passath A, Klein W.
    Clin Pharmacol Ther; 1992 Apr 19; 51(4):445-53. PubMed ID: 1563214
    [Abstract] [Full Text] [Related]

  • 17. Demonstration of beta adrenoceptor blockade by propafenone hydrochloride: clinical pharmacologic, radioligand binding and adenylate cyclase activation studies.
    McLeod AA, Stiles GL, Shand DG.
    J Pharmacol Exp Ther; 1984 Feb 19; 228(2):461-6. PubMed ID: 6141285
    [Abstract] [Full Text] [Related]

  • 18. [Does chronic oral treatment with beta-receptor blockers have an effect on positive inotropic therapy of coronary patients with adrenaline after extracorporeal circulation?].
    Günnicker M, Brinkmann M, Freund U, Piotrowski J, Schieffer M, Velser U.
    Herz; 1995 Dec 19; 20(6):399-411. PubMed ID: 8582699
    [Abstract] [Full Text] [Related]

  • 19. The beta-adrenoceptor subtype(s) mediating adrenaline- and dobutamine-induced blood pressure and heart rate changes in healthy volunteers.
    Daul A, Hermes U, Schäfers RF, Wenzel R, von Birgelen C, Brodde OE.
    Int J Clin Pharmacol Ther; 1995 Mar 19; 33(3):140-8. PubMed ID: 7599912
    [Abstract] [Full Text] [Related]

  • 20. Prominent but reverse stereoselectivity in propranolol glucuronidation by human UDP-glucuronosyltransferases 1A9 and 1A10.
    Sten T, Qvisen S, Uutela P, Luukkanen L, Kostiainen R, Finel M.
    Drug Metab Dispos; 2006 Sep 19; 34(9):1488-94. PubMed ID: 16763014
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.